International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Study of Incidence of Salivary Gland Tumour in Tertiary Care Hospital

Dr Hiranya Prova Saikia, Dr. Nabajyoti Siakia, Dr. Kanchan Chaudhary

Abstract: Salivary gland tumours are relatively few and far when compared to other human tumours. It is said to account for less than 2% of all human tumours1. However, salivary gland tumours make up 3% of all head and neck neoplasm1. About 70% of salivary gland tumour rises from parotid gland where maximum of minor salivary gland tumours are malignant, three-fourth of parotid gland tumours are benign2. Most common type of tumour is pleomorphic adenoma of parotid gland3. The aim of this study was to analyse the various salivary gland tumour according to age, sex, location, histopathological type and strategy of treatment of patients.

Keywords: pleomorphic adenoma, salivary gland tumours, parotid swelling

How to Cite?: Dr Hiranya Prova Saikia, Dr. Nabajyoti Siakia, Dr. Kanchan Chaudhary, "Study of Incidence of Salivary Gland Tumour in Tertiary Care Hospital", Volume 12 Issue 4, April 2023, International Journal of Science and Research (IJSR), Pages: 455-456, https://www.ijsr.net/getabstract.php?paperid=SR23408093541, DOI: https://dx.doi.org/10.21275/SR23408093541

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.